Phenethyl isothiocyanate inhibits androgen receptor-regulated transcriptional activity in prostate cancer cells through suppressing PCAF

Molecular Nutrition and Food Research

Volumn 57, Issue 10, 2013, Pages 1825-1833

  Yu, Chunguang ^a,b   Gong, Ai Yu ^a   Chen, Dongqing ^a   Solelo Leon, Daniel ^a   Young, Charles Yf ^c   Chen, Xian Ming ^a  

^a CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

^b BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^c Mayo Clinic College of Medicine   (United States)

Author keywords

Androgen receptor; MiR 17; P300 CBP associated factor; Phenethyl isothiocyanate; Prostate cancer

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; AR PROTEIN, HUMAN; HISTONE ACETYLTRANSFERASE PCAF; ISOTHIOCYANIC ACID DERIVATIVE; MICRORNA; MIRN17 MICRORNA, HUMAN; P300-CBP-ASSOCIATED FACTOR; PHENETHYL ISOTHIOCYANATE;

ARTICLE; CELL PROLIFERATION; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HUMAN; MALE; METABOLISM; MIR-17; P300/CBP-ASSOCIATED FACTOR; PROSTATE CANCER; PROSTATE TUMOR; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TUMOR CELL LINE; UPREGULATION;

ANDROGEN RECEPTOR; MIR-17; P300/CBP-ASSOCIATED FACTOR; PHENETHYL ISOTHIOCYANATE; PROSTATE CANCER;

CELL LINE, TUMOR; CELL PROLIFERATION; DIHYDROTESTOSTERONE; HUMANS; ISOTHIOCYANATES; MALE; MICRORNAS; P300-CBP TRANSCRIPTION FACTORS; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 84884918893     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201200810     Document Type: Article

References (45)

1. Lippman, S. M., Hawk, E. T., Cancer prevention: from 1727 to milestones of the past 100 years. Cancer Res. 2009, 69, 5269-5284.
2. Huang, J., Plass, C., Gerhäuser, C., Cancer chemoprevention by targeting the epigenome. Curr. Drug Targets 2011, 12, 1925-1956.
3. Huang, Y. W., Kuo, C. T., Stoner, K., Huang, T. H. et al., An overview of epigenetics and chemoprevention. FEBS Lett. 2011, 585, 2129-2136.
4. Jemal, A., Siegel, R., Ward, E., Hao, Y. et al., Cancer statistics, 2008. CA Cancer J. Clin. 2008, 58, 71-96.
5. Culig, Z., Bartsch, G., Androgen axis in prostate cancer. J. Cell. Biochem. 2006, 99, 373-381.
6. Lamont, K. R., Tindall, D. J., Androgen regulation of gene expression. Adv. Cancer Res. 2010, 107, 137-162.
7. Bartel, D. P., MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116, 281-297.
8. Chuang, J. C., Jones, P. A., Epigenetics and microRNAs. Pediatr. Res. 2007, 61, 24R-29R.
9. Sevli, S., Uzumcu, A., Solak, M., Ittmann, M. et al., The function of microRNAs, small but potent molecules, in human prostate cancer. Prostate Cancer Prostatic Dis. 2010, 13, 208-217.
10. Saini, S., Majid, S., Dahiya, R., Diet, microRNAs and prostate cancer. Pharm. Res. 2010, 27, 1014-1026.
11. Kolonel, L. N., Hankin, J. H., Whittemore, A. S., Wu, A. H. et al., Vegetables, fruits, legumes and prostate cancer: a multiethnic case-control study. Cancer Epidemiol. Biomarkers Prev. 2000, 9, 795-804.
12. Cohen, J. H., Kristal, A. R., Stanford, J. L., Fruit and vegetable intakes and prostate cancer risk. J. Natl. Cancer Inst. 2000, 92, 61-68.
13. Stoewsand, G. S., Bioactive organosulfur phytochemicals in Brassica oleracea vegetables-a review. Food Chem. Toxicol. 1995, 33, 537-543.
14. Chung, F. L., Morse, M. A., Eklind, K. I., Lewis, J., Quantitation of human uptake of the anticarcinogen phenethyl isothiocyanate after a watercress meal. Cancer Epidemiol. Biomarkers Prev. 1992, 1, 383-388.
15. Lin, J. M., Amin, S., Trushin, N., Hecht, S. S., Effects of isothiocyanates on tumorigenesis by benzo[a]pyrene in murine tumor models. Cancer Lett. 1993, 74, 151-159.
16. Jiao, D., Eklind, K. I., Choi, C. I., Desai, D. H. et al., Structure-activity relationships of isothiocyanates as mechanism-based inhibitors of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice. Cancer Res. 1994, 54, 4327-4333.
17. Stoner, G. D., Morse, M. A., Isothiocyanates as inhibitors of esophageal cancer. Adv. Exp. Med. Biol. 1996, 401, 13-23.
18. Wang, L. G., Beklemisheva, A., Liu, X. M., Ferrari, A. C. et al., Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer. Mol. Carcinog. 2007, 46, 24-31.
19. Chiao, J. W., Wu, H., Ramaswamy, G., Conaway, C. C. et al., Ingestion of an isothiocyanate metabolite from cruciferous vegetables inhibits growth of human prostate cancer cell xenografts by apoptosis and cell cycle arrest. Carcinogenesis 2004, 25, 1403-1408.
20. Xiao, D., Lew, K. L., Zeng, Y., Xiao, H. et al., Phenethyl isothiocyanate-induced apoptosis in PC-3 human prostate cancer cells is mediated by reactive oxygen species-dependent disruption of the mitochondrial membrane potential. Carcinogenesis 2006, 27, 2223-2234.
21. Nagy, Z., Tora, L., Distinct GCN5/PCAF-containing complexes function as co-activators and are involved in transcription factor and global histone acetylation. Oncogene 2007, 26, 5341-5357.
22. Chmelar, R., Buchanan, G., Need, E. F., Tilley, W. et al., Androgen receptor coregulators and their involvement in the development and progression of prostate cancer. Int. J. Cancer 2007, 120, 719-733.
23. Gao, L., Alumkal, J., Epigenetic regulation of androgen receptor signaling in prostate cancer. Epigenetics 2010, 5, 100-104.
24. Gong, A. Y., Eischeid, A. N., Xiao, J., Zhao, J. et al., miR-17-5p targets the p300/CBP-associated factor and modulates androgen receptor transcriptional activity in cultured prostate cancer cells. BMC Cancer 2012, 12, 492.
25. Gong, A. Y., He, M., Vanaja, D. K., Yin, P. et al., Phenethyl isothiocyanate inhibits STAT3 activation in prostate cancer cells. Mol. Nutr. Food Res. 2009, 53, 878-886.
26. Tilley, W. D., Wilson, C. M., Marcelli, M., McPhaul, M. J., Androgen receptor gene expression in human prostate carcinoma cell lines. Cancer Res. 1990, 15, 5382-5386.
27. Loop, S. M., Rozanski, T. A., Ostenson, R. C. Human primary prostate tumor cell line, ALVA-31: a new model for studying the hormonal regulation of prostate tumor cell growth. Prostate 1993, 22, 93-108.
28. Gong, A. Y., Hu, G., Zhou, R., Liu, J. et al., MicroRNA-221 controls expression of intercellular adhesion molecule-1 in epithelial cells in response to Cryptosporidium parvum infection. Int. J. Parasitol. 2011, 41, 397-403.
29. Gong, A. Y., Zhou, R., Hu, G., Liu, J. et al., Cryptosporidium parvum induces B7-H1 expression in cholangiocytes by downregulating microRNA-513. J. Infect. Dis. 2010, 201, 160-169.
30. Pedersen, I. M., Cheng, G., Wieland, S., Volinia, S. et al., Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 2007, 449, 919-922.
31. Gaughan, L., Logan, I. R., Neal, D. E., Robson, C. N., Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation. Nucleic Acids Res. 2005, 33, 13-26.
32. Xiao, D., Powolny, A. A., Moura, M. B., Kelley, E. E. et al., Phenethyl isothiocyanate inhibits oxidative phosphorylation to trigger reactive oxygen species-mediated death of human prostate cancer cells. J. Biol. Chem. 2010, 285, 26558-26569.
33. Mi, L., Gan, N., Cheema, A., Dakshanamurthy, S. et al., Cancer preventive isothiocyanates induce selective degradation of cellular alpha- and beta-tubulins by proteasomes. J. Biol. Chem. 2009, 284, 17039-17051.
34. Wang, L. G., Liu, X. M., Fang, Y., Dai, W. et al., De-repression of the p21 promoter in prostate cancer cells by an isothiocyanate via inhibition of HDACs and c-Myc. Int. J. Oncol. 2008, 33, 375-380.
35. Fu, M., Wang, C., Reutens, A. T., Angelletti, R. et al., p300 and P/CAF acetylate the androgen receptor at sites governing hormone-dependent transactivation. J. Biol. Chem. 2000, 275, 20853-20860.
36. Reutens, A. T., Fu, M., Wang, C., Albanese, C. et al., Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300/CBP-associated factor (P/CAF)-dependent manner. Mol. Endocrinol. 2001, 15, 797-811.
37. Triboulet, R., Mari, B., Lin, Y. L., Chable-Bessia, C. et al., Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science 2007, 315, 1579-1582.
38. He, L., Hannon, G. J., MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 2004, 5, 522-531.
39. Zhu, R., O'Hara, S. P., Chen, X. M., MicroRNA regulation of innate immune responses in epithelial cells. Cell. Mol. Immunol. 2011, 8, 371-379.
40. Izzotti, A., Larghero, P., Cartiglia, C., Longobardi, M. et al., Modulation of microRNA expression by budesonide, phenethyl isothiocyanate and cigarette smoke in mouse liver and lung. Carcinogenesis 2010, 31, 894-901.
41. Rehmsmeier, M., Steffen, P., Hochsmann, M., Giegerich, R., Fast and effective prediction of microRNA/target duplexes. RNA 2004, 10, 1507-1517.
42. Trompeter, H. I., Abbad, H., Iwaniuk, K. M., Hafner, M. et al., MicroRNAs MiR-17, MiR-20a, and MiR-106b act in concert to modulate E2F activity on cell cycle arrest during neuronal lineage differentiation of USSC. PLoS One 2011, 6, e16138.
43. Xiao, C., Srinivasan, L., Calado, D. P., Patterson, H. C. et al., Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat. Immunol. 2008, 9, 405-414.
44. Shan, S. W., Lee, D. Y., Deng, Z., Shatseva, T. et al., MicroRNA MiR-17 retards tissue growth and represses fibronectin expression. Nat. Cell Biol. 2009, 11, 1031-1038.
45. Mestdagh, P., Boström, A. K., Impens, F., Fredlund, E. et al., The miR-17-92 microRNA cluster regulates multiple components of the TGF-β pathway in neuroblastoma. Mol. Cell 2010, 40, 762-773.